363
Participants
Start Date
May 31, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Calcipotriene Foam
Calcipotriene Foam 0.005%. All treatments will be administered to the skin twice daily (am-pm) for 8 weeks for subjects in this group
Vehicle Foam
Vehicle Foam. All treatments will be administered to the skin twice daily (am-pm) for 8 weeks for subjects in this group
Mt. Sinai School of Medicine Div. Dermatologic & Cosmetic Surgery, New York
Dermatology Associates of Rochester, PC, Rochester
Education and Research Foundation, Lynchburg
Wake Forest University Health Sciences Department of Dermatology, Winston-Salem
Dermatology Consulting Services, High Point
Coastal Carolina Research Center, Mt. Pleasant
Gwinnett Clinical Research Center, Inc., Snellville
MedaPhase, Inc., Newnan
Miami Dermatology Research Institute LLC, North Miami Beach
Tennessee Clinical Research, Nashville
The Skin Wellness Center, PC, Knoxville
Dermatology Specialists, Louisville
DermResearch, PLLC, Louisville
Group Health Associates, Cincinnatti
Grekin Skin Institute, Warren
Henry Ford Medical Center, Detroit
Minnesota Clinical Study Center, Fridley
Central Dermatology PC, St Louis
Suzanne Bruce and Associates, PA, Houston
Dermatology Clinical Research Center of San Antonio, San Antonio
DermReserach, Inc., Austin
Cherry Creek Research, Inc., Denver
Dermatology Research Center, Inc., Salt Lake City
Genova Clinical Research, Tucson
Therapeutics Clinical Research Center, Inc., San Diego
Oregon Medical, Portland
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Stiefel, a GSK Company
INDUSTRY